Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Neurofibroma
Closed
Phase 3
This trial is looking at how well selumetinib might work for plexiform neurofibromas.
Plexiform neurofibromas are not cancer but are a growth on the nerves.
This trial is open to people with type 1 (NF1) who have plexiform neurofibromas that are causing symptoms. And you can’t have surgery to remove them.
Recruitment start: 19 November 2021
Recruitment end: 21 April 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Angela Swampillai
AstraZeneca
Last reviewed: 21 May 2023
CRUK internal database number: 18241
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
